Skip to main content

Advertisement

SpringerLink
Log in

Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Successful treatment of Cushing syndrome causes transient or permanent adrenal insufficiency deriving from endogenous hypercortisolism-induced hypothalamus–pituitary–adrenal–axis suppression. We analyzed pre-treatment factors potentially affecting the duration of adrenal insufficiency. We conducted a retrospective analysis on patients successfully treated for Cushing disease (15 patients) who underwent transsphenoidal surgery, and nonmalignant primary adrenal Cushing syndrome (31 patients) who underwent unilateral adrenalectomy, divided into patients with overt primary adrenal Cushing syndrome (14 patients) and subclinical primary adrenal Cushing syndrome (17 patients). Epidemiological data, medical history, and hormonal parameters depending on the etiology of hypercortisolism were collected and compared to the duration of adrenal insufficiency. The median duration of follow-up after surgery for Cushing disease and primary adrenal Cushing syndrome was 70 and 48 months, respectively. In the Cushing disease group, the median duration of adrenal insufficiency after transsphenoidal surgery was 15 months: younger age at diagnosis and longer duration of signs and symptoms of hypercortisolism before diagnosis and surgery were associated with longer duration of adrenal insufficiency. The median duration of adrenal insufficiency was 6 months for subclinical primary adrenal Cushing syndrome and 18.5 months for overt primary adrenal Cushing syndrome. The biochemical severity of hypercortisolism, the grade of hypothalamus–pituitary–adrenal–axis suppression, and treatment with ketoconazole before surgery accounted for longer duration of adrenal insufficiency. In patients with Cushing disease, younger age and delayed diagnosis and treatment predict longer need for glucocorticoid replacement therapy after successful transsphenoidal surgery. In patients with primary adrenal Cushing syndrome, the severity of hypercortisolism plays a primary role in influencing the duration of adrenal insufficiency after unilateral adrenalectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. J. Newell-Price, X. Bertagna, A.B. Grossman, L.K. Nieman, Cushing’s syndrome. Lancet 367(9522), 1605–1617 (2006). doi:10.1016/S0140-6736(06)68699-6

    Article  CAS  PubMed  Google Scholar 

  2. L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(5), 1526–1540 (2008). doi:10.1210/jc.2008-0125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. C.M. Berr, G. Di Dalmazi, A. Osswald, K. Ritzel, M. Bidlingmaier, L.L. Geyer, M. Treitl, K. Hallfeldt, W. Rachinger, N. Reisch, R. Blaser, J. Schopohl, F. Beuschlein, M. Reincke, Time to recovery of adrenal function after curative surgery for Cushing’s syndrome depends on etiology. J. Clin. Endocrinol. Metab. 100(4), 1300–1308 (2015). doi:10.1210/jc.2014-3632

    Article  CAS  PubMed  Google Scholar 

  4. T. Deutschbein, M. Broecker-Preuss, M.F. Hartmann, R. Althoff, S.A. Wudy, K. Mann, S. Petersenn, Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism. Horm. Metab. Res. 43(10), 714–719 (2011). doi:10.1055/s-0031-1286297

    Article  CAS  PubMed  Google Scholar 

  5. S. Persichilli, J. Gervasoni, F. Iavarone, C. Zuppi, A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose. Clin. Chem. Lab. Med. 48(10), 1433–1437 (2010). doi:10.1515/CCLM.2010.282

    Article  CAS  PubMed  Google Scholar 

  6. M. Sereg, A. Szappanos, J. Toke, K. Karlinger, K. Feldman, E. Kaszper, I. Varga, E. Glaz, K. Racz, M. Toth, Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur. J. Endocrinol. 160(4), 647–655 (2009). doi:10.1530/EJE-08-0707

    Article  CAS  PubMed  Google Scholar 

  7. M. Terzolo, S. Bovio, A. Pia, P.A. Conton, G. Reimondo, C. Dall’Asta, D. Bemporad, A. Angeli, G. Opocher, M. Mannelli, B. Ambrosi, F. Mantero, Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur. J. Endocrinol. 153(2), 307–315 (2005). doi:10.1530/eje.1.01959

    Article  CAS  PubMed  Google Scholar 

  8. I. Chiodini, Clinical review: diagnosis and treatment of subclinical hypercortisolism. J. Clin. Endocrinol. Metab. 96(5), 1223–1236 (2011). doi:10.1210/jc.2010-2722

    Article  CAS  PubMed  Google Scholar 

  9. F. Esposito, J.R. Dusick, P. Cohan, P. Moftakhar, D. McArthur, C. Wang, R.S. Swerdloff, D.F. Kelly, Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J. Clin. Endocrinol. Metab. 91(1), 7–13 (2006). doi:10.1210/jc.2005-1204

    Article  CAS  PubMed  Google Scholar 

  10. G. Di Dalmazi, C.M. Berr, M. Fassnacht, F. Beuschlein, M. Reincke, Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing’s syndrome: a systematic review of the literature. J. Clin. Endocrinol. Metab. 99(8), 2637–2645 (2014). doi:10.1210/jc.2014-1401

    Article  PubMed  Google Scholar 

  11. P.A. Fitzgerald, D.C. Aron, J.W. Findling, R.M. Brooks, C.B. Wilson, P.H. Forsham, J.B. Tyrrell, Cushing’s disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J. Clin. Endocrinol. Metab. 54(2), 413–422 (1982). doi:10.1210/jcem-54-2-413

    Article  CAS  PubMed  Google Scholar 

  12. A.R. Hermus, G.F. Pieters, G.J. Pesman, E. Meijer, A.G. Smals, T.J. Benraad, P.W. Kloppenborg, Coexistence of hypothalamic and pituitary failure after successful pituitary surgery in Cushing’s disease?. J. Endocrinol. Invest. 10(4), 365–369 (1987). doi:10.1007/BF03348149

    Article  CAS  PubMed  Google Scholar 

  13. J. Flitsch, D.K. Ludecke, U.J. Knappe, W. Saeger, Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing’s disease. Exp. Clin. Endocrinol. Diabetes 107(3), 183–189 (1999). doi:10.1055/s-0029-1212095

    Article  CAS  PubMed  Google Scholar 

  14. M. Lodish, S.V. Dunn, N. Sinaii, M.F. Keil, C.A. Stratakis, Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing’s disease. J. Clin. Endocrinol. Metab. 97(5), 1483–1491 (2012). doi:10.1210/jc.2011-2325

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. D. Bochicchio, M. Losa, M. Buchfelder, Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s disease survey group. J. Clin. Endocrinol. Metab. 80(11), 3114–3120 (1995). doi:10.1210/jcem.80.11.7593411

    CAS  PubMed  Google Scholar 

  16. N. Sonino, M. Zielezny, G.A. Fava, F. Fallo, M. Boscaro, Risk factors and long-term outcome in pituitary-dependent Cushing’s disease. J. Clin. Endocrinol. Metab. 81(7), 2647–2652 (1996). doi:10.1210/jcem.81.7.8675592

    CAS  PubMed  Google Scholar 

  17. S.H. Roerink, M.A. Wagenmakers, J.W. Smit, E.F. van Rossum, R.T. Netea-Maier, T.S. Plantinga, A.R. Hermus, Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing’s syndrome. Endocrine (2016). doi:10.1007/s12020-016-0883-z

  18. O. Ragnarsson, C.A. Glad, P. Berglund, R. Bergthorsdottir, D.N. Eder, G. Johannsson, Common genetic variants in the glucocorticoid receptor and the 11beta-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing’s syndrome in remission. J. Clin. Endocrinol. Metab. 99(9), E1803–1807 (2014). doi:10.1210/jc.2014-1906

    Article  CAS  PubMed  Google Scholar 

  19. L. Trementino, G. Appolloni, C. Concettoni, M. Cardinaletti, M. Boscaro, G. Arnaldi, Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing’s syndrome. Eur. J. Endocrinol. 166(1), 35–42 (2012). doi:10.1530/EJE-11-0722

    Article  CAS  PubMed  Google Scholar 

  20. M.P. Ricciato, V. Di Donna, G. Perotti, A. Pontecorvi, R. Bellantone, S.M. Corsello, The role of adrenal scintigraphy in the diagnosis of subclinical Cushing’s syndrome and the prediction of post-surgical hypoadrenalism. World J. Surg. 38(6), 1328–1335 (2014). doi:10.1007/s00268-014-2482-6

    PubMed  Google Scholar 

  21. L.M. Fig, M.D. Gross, B. Shapiro, D.A. Ehrmann, J.E. Freitas, D.E. Schteingart, G.M. Glazer, I.R. Francis, Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome. Ann. Intern. Med. 109(7), 547–553 (1988)

    Article  CAS  PubMed  Google Scholar 

  22. D. Rubello, C. Bui, D. Casara, M.D. Gross, L.M. Fig, B. Shapiro, Functional scintigraphy of the adrenal gland. Eur. J. Endocrinol. 147(1), 13–28 (2002)

    Article  CAS  PubMed  Google Scholar 

  23. A.M. Avram, L.M. Fig, M.D. Gross, Adrenal gland scintigraphy. Semin. Nucl. Med. 36(3), 212–227 (2006). doi:10.1053/j.semnuclmed.2006.03.004

    Article  PubMed  Google Scholar 

  24. F. Donadio, V. Morelli, A.S. Salcuni, C. Eller-Vainicher, M. Carletto, M. Castellani, L. Dellavedova, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass. J. Endocrinol. Invest. 32(7), 576–580 (2009). doi:10.3275/6360

    Article  CAS  PubMed  Google Scholar 

  25. G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease?. Eur. J. Endocrinol. 173(4), M61–71 (2015). doi:10.1530/EJE-15-0272

    Article  PubMed  Google Scholar 

  26. J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, M. Besser, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin. Endocrinol. 43(5), 545–550 (1995)

    Article  CAS  Google Scholar 

  27. F. Pecori Giraldi, A.G. Ambrogio, M. De Martin, L.M. Fatti, M. Scacchi, F. Cavagnini, Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J. Clin. Endocrinol. Metab. 92(11), 4123–4129 (2007). doi:10.1210/jc.2007-0596

    Article  PubMed  Google Scholar 

  28. J. Shen, M. Sun, B. Zhou, J. Yan, Nonconformity in the clinical practice guidelines for subclinical Cushing’s syndrome: which guidelines are trustworthy?. Eur. J. Endocrinol. 171(4), 421–431 (2014). doi:10.1530/EJE-14-0345

    Article  CAS  PubMed  Google Scholar 

  29. M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, Italian Association of Clinical, E.: AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164(6), 851–870 (2011). doi:10.1530/EJE-10-1147

    Article  CAS  PubMed  Google Scholar 

  30. C. Eller-Vainicher, V. Morelli, A.S. Salcuni, M. Torlontano, F. Coletti, L. Iorio, A. Cuttitta, A. Ambrosio, L. Vicentini, V. Carnevale, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, I. Chiodini, Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?. Eur. J. Endocrinol. 162(1), 91–99 (2010). doi:10.1530/EJE-09-0775

    Article  PubMed  Google Scholar 

  31. S. Kidambi, H. Raff, J.W. Findling, Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur. J. Endocrinol. 157(6), 725–731 (2007). doi:10.1530/EJE-07-0424

    Article  CAS  PubMed  Google Scholar 

  32. K.I. Alexandraki, A.B. Grossman, Is urinary free cortisol of value in the diagnosis of Cushing’s syndrome?. Curr. Opin. Endocrinol. Diabetes Obes. 18(4), 259–263 (2011). doi:10.1097/MED.0b013e3283487193

    Article  CAS  PubMed  Google Scholar 

  33. N. Krone, B.A. Hughes, G.G. Lavery, P.M. Stewart, W. Arlt, C.H. Shackleton, Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J. Steroid Biochem. Mol. Biol. 121(3-5), 496–504 (2010). doi:10.1016/j.jsbmb.2010.04.010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unit of Endocrinology, Facoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, Rome, 00168, Italy

    Alessandro Prete, Rosa Maria Paragliola, Filomena Bottiglieri, Carlo Antonio Rota, Alfredo Pontecorvi & Salvatore Maria Corsello

  2. Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, and Pituitary Center Johns Hopkins University School of Medicine, 773 N Broadway, Baltimore, MD, 21205, USA

    Roberto Salvatori

Authors
  1. Alessandro Prete
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosa Maria Paragliola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Filomena Bottiglieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlo Antonio Rota
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alfredo Pontecorvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roberto Salvatori
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Salvatore Maria Corsello
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salvatore Maria Corsello.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prete, A., Paragliola, R.M., Bottiglieri, F. et al. Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome. Endocrine 55, 969–980 (2017). https://doi.org/10.1007/s12020-016-1007-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-1007-5

Keywords

Search

Navigation